★ Sign in to follow
PP

Promore Pharma Stock: price and insider trades · Sweden

ISIN SE0009947740SE·

No insider purchase over the last 90 days. The latest, by Anne Dorney, was filed 14 Mar 2024.

Promore Pharma: what insiders have been doing

This page follows insider dealings at Promore Pharma as filed with Finansinspektionen. Nothing new has been filed by managers of Promore Pharma in twelve months, the latest record being from 14 March 2024.

The full history, which starts in 2017, counts 27 purchases against 1 sale.

In the same market, recent insider purchases at Dynavox Group AB and Rusta AB (publ) also feature in our signals. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Insider Decl.
37
Thresholds
n/a
Buy Volume
€517,207
27 ops. · all time
Sell Volume
€710
1 ops. · all time
Last declaration on 14 March 2024
Declarations37 total
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    440,545 SEK9FI-SE
    37,800 shares@ SEK 11.654622.6% of flowAktieISIN SE0021513645FI:csv-22231afd8fa90ab9d2c4
    Canonical exit: 10 Jun 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    303,026 SEK9FI-SE
    25,000 shares@ SEK 12.12115.6% of flowAktieISIN SE0021513645FI:csv-22bc9f45ab959d7c8fbc
    Canonical exit: 9 Jun 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    10,188 SEK7FI-SE
    900 shares@ SEK 11.31940.5% of flowAktieISIN SE0021513645FI:csv-8955ce1d7b4be8bddc32
    Canonical exit: 10 Jun 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    426,952 SEK9FI-SE
    37,000 shares@ SEK 11.539321.9% of flowAktieISIN SE0021513645FI:csv-0be963ab475617a639fe
    Canonical exit: 5 Jun 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    219,828 SEK8FI-SE
    18,000 shares@ SEK 12.212711.2% of flowAktieISIN SE0021513645FI:csv-7eb06c86acf5a6e7839e
    Canonical exit: 4 Jun 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    191,480 SEK8FI-SE
    17,200 shares@ SEK 11.13269.8% of flowAktieISIN SE0021513645FI:csv-56eab7f23c652f8943a5
    Canonical exit: 4 Jun 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    33 SEK7FI-SE
    3.279 shares@ SEK 9.94820.0% of flowAktieISIN SE0021513645FI:csv-acaa19c16c32a01a9f2e
    Canonical exit: 29 May 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    157 SEK7FI-SE
    14.721 shares@ SEK 10.65150.0% of flowAktieISIN SE0021513645FI:csv-db3439ca33a0667966ae
    Canonical exit: 30 May 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    53,528 SEK7FI-SE
    208,000 shares@ SEK 0.25732.7% of flowAktieISIN SE0009947740FI:csv-888a85a5ec7ee9b14c02
    Canonical exit: 21 Apr 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    54,278 SEK7FI-SE
    430,000 shares@ SEK 0.12622.7% of flowAktieISIN SE0009947740FI:csv-0823e6ef4ce4270b9df2
    Canonical exit: 16 Apr 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    30,632 SEK7FI-SE
    275,000 shares@ SEK 0.11141.6% of flowAktieISIN SE0009947740FI:csv-f554db89169e1cfe0827
    Canonical exit: 15 Apr 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    11,275 SEK7FI-SE
    110,000 shares@ SEK 0.10250.6% of flowAktieISIN SE0009947740FI:csv-855339d1befe34c52e34
    Canonical exit: 15 Apr 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    56,463 SEK7FI-SE
    435,000 shares@ SEK 0.12982.9% of flowAktieISIN SE0009947740FI:csv-8e5ad8acb01e531d45d1
    Canonical exit: 16 Apr 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    51,305 SEK7FI-SE
    348,506 shares@ SEK 0.14722.6% of flowAktieISIN SE0009947740FI:csv-733996bf3210026672a1
    Canonical exit: 17 Apr 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    57,575 SEK7FI-SE
    348,540 shares@ SEK 0.16522.9% of flowAktieISIN SE0009947740FI:csv-2cf29407998d27974719
    Canonical exit: 17 Apr 2024 (T+90)
  • ▲
    Anne Dorney
    StyrelseledamotExecutives
    48,110 SEK7FI-SE
    255,000 shares@ SEK 0.18872.4% of flowAktieISIN SE0009947740FI:csv-79d2805e9362a27eb283
    Canonical exit: 18 Apr 2024 (T+90)
  • ▲
    Erik Magnusson
    Ekonomichef/finanschef/finansdirektörExecutives
    25,045 SEK22FI-SE
    8,666 shares@ SEK 2.8929.5% of flowAktieISIN SE0009947740FI:csv-522a5e45e184585c31e7
    Canonical exit: 29 Jun 2021 (T+90)
  • ▲
    Erik Magnusson
    Ekonomichef/finanschef/finansdirektörExecutives
    14,558 SEK33FI-SE
    4,044 shares@ SEK 3.6024.6% of flowAktieISIN SE0009947740FI:csv-44abd459bb41971a9f24
    Canonical exit: 24 Feb 2021 (T+90)
  • ▲
    Erik Magnusson
    Ekonomichef/finanschef/finansdirektörExecutives
    10,980 SEK33FI-SE
    3,000 shares@ SEK 3.6618.6% of flowAktieISIN SE0009947740FI:csv-fe6c08e81c89de3d0860
    Canonical exit: 24 Feb 2021 (T+90)
  • ▲
    Jonas Ekblom
    Verkställande direktör (VD)Executives
    38,000 SEK38FI-SE
    10,000 shares@ SEK 3.8036.6% of flowAktieISIN SE0009947740FI:csv-87deec93cfb0a4c14cde
    Canonical exit: 24 Feb 2021 (T+90)
  • ▲
    Erik Magnusson
    Ekonomichef/finanschef/finansdirektörExecutives
    33,622 SEK25FI-SE
    10,000 shares@ SEK 3.362256.8% of flowAktieISIN SE0009947740FI:csv-883c59d6859b5dc61bf8
    Canonical exit: 23 Feb 2021 (T+90)
  • ●
    Göran Linder
    Styrelseledamot/suppleantExecutives
    25M SEK0FI-SE
    6,813,219 shares@ SEK 3.7193.7% of flowBTA (betald tecknad aktie)ISIN SE0013359072FI:csv-16cf58d6df127820df1c
  • ●
    Jenni Fredrika Björnulfson
    Ekonomi/finanschefExecutives
    14,840 SEK0FI-SE
    4,000 shares@ SEK 3.7125.3% of flowBTA (betald tecknad aktie)ISIN SE0009947740FI:csv-4c48ab3dc750cb28ae46
  • ●
    Ulrika Wennberg
    COOExecutives
    1,855 SEK0FI-SE
    500 shares@ SEK 3.7112.7% of flowBTA (betald tecknad aktie)ISIN SE0013359072FI:csv-9ba2e4d095379e02f801
  • ▲
    Jonas Ekblom
    VDExecutives
    27,621 SEK25FI-SE
    7,445 shares@ SEK 3.7125.6% of flowAktieISIN SE0009947740FI:csv-68ed390eb4dda3a88cb1
    Canonical exit: 26 Feb 2020 (T+90)

25 of 37 declarations

About Promore Pharma

Promore Pharma is a biopharmaceutical company focused on developing treatments for serious diseases. It is listed on the XSTO exchange.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations

Related companies and executives

No related entities found.